294 related articles for article (PubMed ID: 9462168)
1. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
Bootsma H; Spronk PE; Ter Borg EJ; Hummel EJ; de Boer G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168
[TBL] [Abstract][Full Text] [Related]
2. Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies.
Bootsma H; Spronk PE; Hummel EJ; de Boer G; ter Borg EJ; Limburg PC; Kallenberg CG
Scand J Rheumatol; 1996; 25(6):352-9. PubMed ID: 8996469
[TBL] [Abstract][Full Text] [Related]
3. Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.
ter Borg EJ; Horst G; Hummel E; Limburg PC; Kallenberg CG
Clin Immunol Immunopathol; 1991 Apr; 59(1):117-28. PubMed ID: 2019007
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
6. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.
ter Borg EJ; Horst G; Hummel EJ; Limburg PC; Kallenberg CG
Arthritis Rheum; 1990 May; 33(5):634-43. PubMed ID: 2346519
[TBL] [Abstract][Full Text] [Related]
7. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S
Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test.
Werle E; Blazek M; Fiehn W
Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405
[TBL] [Abstract][Full Text] [Related]
9. Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Guialis A; Tzioufas G; Moutsopoulos HM
Br J Rheumatol; 1996 Jun; 35(6):534-41. PubMed ID: 8670573
[TBL] [Abstract][Full Text] [Related]
10. A cross-sectional study of anti-DNA antibodies in the serum and IgG and IgM fraction of healthy individuals, patients with systemic lupus erythematosus and their relatives.
Williams WM; Isenberg DA
Lupus; 1996 Dec; 5(6):576-86. PubMed ID: 9116700
[TBL] [Abstract][Full Text] [Related]
11. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients.
Hylkema MN; van Bruggen MC; ten Hove T; de Jong J; Swaak AJ; Berden JH; Smeenk RJ
J Autoimmun; 2000 Mar; 14(2):159-68. PubMed ID: 10677247
[TBL] [Abstract][Full Text] [Related]
12. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
Kim KH; Han JY; Kim JM; Lee SW; Chung WT
Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
[TBL] [Abstract][Full Text] [Related]
14. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
[TBL] [Abstract][Full Text] [Related]
15. Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity.
Tzioufas AG; Manoussakis MN; Drosos AA; Silis G; Gharavi AE; Moutsopoulos HM
Clin Exp Rheumatol; 1987; 5(3):247-53. PubMed ID: 3501355
[TBL] [Abstract][Full Text] [Related]
16. Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS).
Ehrenstein MR; Swana M; Keeling D; Asherson R; Hughes GR; Isenberg DA
Br J Rheumatol; 1993 May; 32(5):362-5. PubMed ID: 8495254
[TBL] [Abstract][Full Text] [Related]
17. The use of laboratory tests in the diagnosis of SLE.
Egner W
J Clin Pathol; 2000 Jun; 53(6):424-32. PubMed ID: 10911799
[TBL] [Abstract][Full Text] [Related]
18. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.
Neogi T; Gladman DD; Ibanez D; Urowitz M
J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus.
Krippner H; Springer B; Merle S; Pirlet K
Clin Exp Immunol; 1984 Oct; 58(1):49-56. PubMed ID: 6332696
[TBL] [Abstract][Full Text] [Related]
20. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
